Tonix Pharmaceuticals Holding shares are trading lower after the company announced the pricing of a $4.4 million registered direct offering.
Portfolio Pulse from Benzinga Newsdesk
Tonix Pharmaceuticals Holding Corp. (TNXP) shares are trading lower following the announcement of a $4.4 million registered direct offering.

March 28, 2024 | 3:21 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Tonix Pharmaceuticals Holding Corp. announced a $4.4 million registered direct offering, leading to a decrease in its share price.
The announcement of a registered direct offering often leads to a decrease in share price due to the dilution of existing shares. Investors may view this as a negative signal about the company's current cash position or its future financial prospects, leading to a short-term negative impact on the stock.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100